Market Cap | ₹45,051Cr |
ROE | 47.54% |
P/E Ratio(TTM) | 47.41 |
EPS(TTM) | 56.09 |
P/B Ratio | 23.09 |
Dividend Yield | 2.03% |
Industry P/E | 33.86 |
Book Value | 115.19 |
Debt to Equity | 0.01 |
Face Value | 10 |
Parent Organisation | GlaxoSmithKline Pharmaceuticals Limited |
Managing Director | Mr. Bhushan Akshikar |
NSE Symbol | GLAXO |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Abbott India | NA (0.00%) | 43.38 | ||
Pfizer | NA (0.00%) | 27.80 | ||
Astrazeneca Pharma India | NA (0.00%) | 121.17 | ||
Sanofi Consumer Healthcare India | NA (0.00%) | 55.31 |